Interferon therapy reduces the risk for hepatocellular carcinoma

Gut

Volumn 47, Issue 5, 2000, Pages 610-611

  Brown, J L ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS LOAD;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER NEOPLASMS; MALE; RISK FACTORS; VIRAL LOAD;

EID: 0033756370     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.5.610     Document Type: Note

References (10)

1. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
2. Treatment of hepatitis C virus related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
3. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
4. International Interferon-α Hepatocellular Carcinoma Study Group Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
5. Determinants of outcome of compensated hepatitis C virus-related cirrhosis
6. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
7. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
8. 45-year follow-up of hepatitis C virus infection in healthy young adults
9. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
10. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death